U.S. markets close in 1 hour 34 minutes
  • S&P 500

    3,663.70
    +1.25 (+0.03%)
     
  • Dow 30

    29,825.18
    +1.26 (+0.00%)
     
  • Nasdaq

    12,329.69
    -25.42 (-0.21%)
     
  • Russell 2000

    1,830.15
    -5.89 (-0.32%)
     
  • Crude Oil

    45.25
    +0.70 (+1.57%)
     
  • Gold

    1,831.80
    +12.90 (+0.71%)
     
  • Silver

    24.10
    +0.01 (+0.04%)
     
  • EUR/USD

    1.2105
    +0.0026 (+0.22%)
     
  • 10-Yr Bond

    0.9490
    +0.0150 (+1.61%)
     
  • GBP/USD

    1.3366
    -0.0057 (-0.42%)
     
  • USD/JPY

    104.5090
    +0.1930 (+0.19%)
     
  • BTC-USD

    18,981.08
    -12.82 (-0.07%)
     
  • CMC Crypto 200

    372.48
    +7.56 (+2.07%)
     
  • FTSE 100

    6,463.39
    +78.66 (+1.23%)
     
  • Nikkei 225

    26,800.98
    +13.44 (+0.05%)
     

This company gets FDA green light to proceed with study on possible COVID-19 treatment

Vanda Pharmaceuticals CEO Dr. Mihael Polymeropoulos joins Yahoo Finance's Seana Smith on what's next for the company's potential coronavirus treatment drug after receiving approval from the FDA for a clinical trial.